These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Immunosuppressive properties of mesenchymal stem cells: advances and applications. De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979 [TBL] [Abstract][Full Text] [Related]
23. The plasticity of human Treg and Th17 cells and its role in autoimmunity. Kleinewietfeld M; Hafler DA Semin Immunol; 2013 Nov; 25(4):305-12. PubMed ID: 24211039 [TBL] [Abstract][Full Text] [Related]
24. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model. Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894 [TBL] [Abstract][Full Text] [Related]
25. Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells. Ribeiro A; Laranjeira P; Mendes S; Velada I; Leite C; Andrade P; Santos F; Henriques A; Grãos M; Cardoso CM; Martinho A; Pais M; da Silva CL; Cabral J; Trindade H; Paiva A Stem Cell Res Ther; 2013 Oct; 4(5):125. PubMed ID: 24406104 [TBL] [Abstract][Full Text] [Related]
26. Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Groh ME; Maitra B; Szekely E; Koç ON Exp Hematol; 2005 Aug; 33(8):928-34. PubMed ID: 16038786 [TBL] [Abstract][Full Text] [Related]
27. Dysregulated balance in Th17/Treg axis of Pristane-induced lupus mouse model, are mesenchymal stem cells therapeutic? Hoseinzadeh A; Rezaieyazdi Z; Mahmoudi M; Tavakol Afshari J; Lavi Arab F; Esmaeili SA; Faridzadeh A; Rezaeian A; Hoseini S; Barati M; Mahmoudi A; Sadat Tabasi N Int Immunopharmacol; 2023 Apr; 117():109699. PubMed ID: 36867923 [TBL] [Abstract][Full Text] [Related]
28. Transfer of mesenchymal stem cell mitochondria to CD4 Akhter W; Nakhle J; Vaillant L; Garcin G; Le Saout C; Simon M; Crozet C; Djouad F; Jorgensen C; Vignais ML; Hernandez J Stem Cell Res Ther; 2023 Jan; 14(1):12. PubMed ID: 36694226 [TBL] [Abstract][Full Text] [Related]
29. Immunomodulatory effects of adipose-derived mesenchymal stem cells on the gene expression of major transcription factors of T cell subsets. Mohammadzadeh A; Pourfathollah AA; Shahrokhi S; Hashemi SM; Moradi SL; Soleimani M Int Immunopharmacol; 2014 Jun; 20(2):316-21. PubMed ID: 24704622 [TBL] [Abstract][Full Text] [Related]
30. Therapeutic administration of bone marrow-derived mesenchymal stromal cells reduces airway inflammation without up-regulating Tregs in experimental asthma. Kitoko JZ; de Castro LL; Nascimento AP; Abreu SC; Cruz FF; Arantes AC; Xisto DG; Martins MA; Morales MM; Rocco PRM; Olsen PC Clin Exp Allergy; 2018 Feb; 48(2):205-216. PubMed ID: 29068567 [TBL] [Abstract][Full Text] [Related]
31. Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor. Duffy MM; Pindjakova J; Hanley SA; McCarthy C; Weidhofer GA; Sweeney EM; English K; Shaw G; Murphy JM; Barry FP; Mahon BP; Belton O; Ceredig R; Griffin MD Eur J Immunol; 2011 Oct; 41(10):2840-51. PubMed ID: 21710489 [TBL] [Abstract][Full Text] [Related]
32. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models. Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502 [TBL] [Abstract][Full Text] [Related]
33. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946 [TBL] [Abstract][Full Text] [Related]
34. Mesenchymal stem cells attenuate acute liver injury by altering ratio between interleukin 17 producing and regulatory natural killer T cells. Milosavljevic N; Gazdic M; Simovic Markovic B; Arsenijevic A; Nurkovic J; Dolicanin Z; Djonov V; Lukic ML; Volarevic V Liver Transpl; 2017 Aug; 23(8):1040-1050. PubMed ID: 28481005 [TBL] [Abstract][Full Text] [Related]
36. Mesenchymal Stem Cell: A Friend or Foe in Anti-Tumor Immunity. Harrell CR; Volarevic A; Djonov VG; Jovicic N; Volarevic V Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830312 [TBL] [Abstract][Full Text] [Related]
37. Anti-VCAM 1 Antibody-Coated Mesenchymal Stromal Cells Attenuate Experimental Colitis via Immunomodulation. Chen Q; Li Y; Chen Z; Du H; Wan J Med Sci Monit; 2019 Jun; 25():4457-4468. PubMed ID: 31201771 [TBL] [Abstract][Full Text] [Related]
38. Stability and function of regulatory T cells expressing the transcription factor T-bet. Levine AG; Mendoza A; Hemmers S; Moltedo B; Niec RE; Schizas M; Hoyos BE; Putintseva EV; Chaudhry A; Dikiy S; Fujisawa S; Chudakov DM; Treuting PM; Rudensky AY Nature; 2017 Jun; 546(7658):421-425. PubMed ID: 28607488 [TBL] [Abstract][Full Text] [Related]
39. Pre-differentiated Th1 and Th17 effector T cells in autoimmune gastritis: Ag-specific regulatory T cells are more potent suppressors than polyclonal regulatory T cells. Huter EN; Stummvoll GH; DiPaolo RJ; Glass DD; Shevach EM Int Immunopharmacol; 2009 May; 9(5):540-5. PubMed ID: 19539565 [TBL] [Abstract][Full Text] [Related]
40. Graded RhoA GTPase Expression in Treg Cells Distinguishes Tumor Immunity From Autoimmunity. Kalim KW; Yang JQ; Modur V; Nguyen P; Li Y; Zheng Y; Guo F Front Immunol; 2021; 12():726393. PubMed ID: 34721389 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]